Siva Narayanan | Vice President

Siva Narayanan, Vice President, PTC

Siva has two decades of experience in developing and communicating product value propositions through market access strategies, research excellence, and brand strategy support. Siva is a veteran of the industry with leadership roles at PTC Therapeutics, Human Genome Sciences/GSK, BMS, Merck & Co. and Boehringer-Ingelheim, covering several therapeutic areas and markets. Siva led market access related consulting divisions at MKTXS, Ipsos Healthcare and TNS (now, part of Kantar) respectively in the capacities of SVP/EVP, helping biopharmaceutical clients demonstrate and articulate product value propositions to achieve optimal access globally and market share while maintaining the pricing corridor. Siva has a strong publication track record and has presented at various scientific and trade conferences and to diverse payer audiences. Siva has a Master’s degree in Health Policy and Management from Johns Hopkins University, and a Master’s degree in Bioengineering from University of Strathclyde, UK.


Day One World Pharma Pricing & Market Access EU Congress @ 15:40

Regulatory landscape and the implications for clinical trial design in rare/ultra-rare diseases

  • An update on EU regulatory landscape pertaining to orphan and ultra-orphan diseases
  • Implications for clinical trial design, as well as post-authorization evidence development
  • Implications for HTA in Europe 

back to speakers